Evidence map›Paper›PMID 29880880›Full record

ArticleMolecular psychiatry2018

DNA sequence-level analyses reveal potential phenotypic modifiers in a large family with psychiatric disorders.

Niamh M Ryan, Jayon Lihm, Melissa Kramer, Shane McCarthy, Stewart W Morris, Aleix Arnau-Soler, Gail Davies, Barbara Duff, Elena Ghiban, Caroline Hayward and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Locus-Specific Genetic Associations at theAdvanced genetics (Hoboken, N.J.) · 2026
    Article
  2. Article
  3. Review
  4. The Influence of a Genetic Variant inInternational journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Astrocytes in schizophrenia.Brain and neuroscience advances
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Niamh M RyanCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Jayon LihmStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, New York, USA.
Melissa KramerStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, New York, USA.
Shane McCarthyStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, New York, USA.
Stewart W MorrisCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Aleix Arnau-SolerCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Gail DaviesCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
Barbara DuffDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Elena GhibanStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, New York, USA.
Caroline HaywardMRC Human Genetics Unit, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-9405-9550
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.
Douglas H R BlackwoodDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-4076-9346
Stephen M LawrieDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID http://orcid.org/0000-0002-2444-5675
Andrew M McIntoshCentre for Cognitive Ageing and Cognitive Epidemiology, Department of Psychology, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-0198-4588
Kathryn L EvansCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
David J PorteousCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK. david.porteous@ed.ac.uk.ORCID http://orcid.org/0000-0003-1249-6106
W Richard McCombieStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, New York, USA. mccombie@cshl.edu.
Pippa A ThomsonCentre for Genomic and Experimental Medicine, MRC Institute of Genetic and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Pippa.Thomson@ed.ac.uk.ORCID http://orcid.org/0000-0002-4208-5271
Cold Spring Harbor Laboratory · USInstitute of Genetics and Cancer · GBRoyal Edinburgh Hospital · GBUniversity of Edinburgh · GBAlzheimer Scotland · GBEdinburgh Cancer Research · GB

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI John Edward Moses · 1987 to 2026
$118.9M
Testing the DISC1 pathway for functional genetic variation and epistasis in majorR01MH102068 · NIMH · COLD SPRING HARBOR LABORATORY · PI MCCOMBIE, WILLIAM RICHARD, PORTEOUS, DAVID J · 2013 to 2015
$2.0M
Chief Scientist Office SCD/12Medical Research Council MC_UU_00007/10Medical Research Council MR/J004367/1Medical Research Council MR/K026992/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C011202/1NCI NIH HHS P30 CA045508NIMH NIH HHS R01 MH102068Wellcome Trust
6 · The paper itself

Abstract

Psychiatric disorders are a group of genetically related diseases with highly polygenic architectures. Genome-wide association analyses have made substantial progress towards understanding the genetic architecture of these disorders. More recently, exome- and whole-genome sequencing of cases and families have identified rare, high penetrant variants that provide direct functional insight. There remains, however, a gap in the heritability explained by these complementary approaches. To understand how multiple genetic variants combine to modify both severity and penetrance of a highly penetrant variant, we sequenced 48 whole genomes from a family with a high loading of psychiatric disorder linked to a balanced chromosomal translocation. The (1;11)(q42;q14.3) translocation directly disrupts three genes: DISC1, DISC2, DISC1FP and has been linked to multiple brain imaging and neurocognitive outcomes in the family. Using DNA sequence-level linkage analysis, functional annotation and population-based association, we identified common and rare variants in GRM5 (minor allele frequency (MAF) > 0.05), PDE4D (MAF > 0.2) and CNTN5 (MAF < 0.01) that may help explain the individual differences in phenotypic expression in the family. We suggest that whole-genome sequencing in large families will improve the understanding of the combined effects of the rare and common sequence variation underlying psychiatric phenotypes.

Indexed as

AdultAllelesContactinsCyclic Nucleotide Phosphodiesterases, Type 4FamilyFemaleGene FrequencyGenetic LinkageGenetic Predisposition to DiseaseGenetic TestingGenome-Wide Association StudyGenomicsGenotypeHumansLod ScoreMaleCNTN5 protein, humanContactinsCyclic Nucleotide Phosphodiesterases, Type 4DISC1FP1 non-coding RNA, humanDISC1 protein, humanDISC2 gene product, humanGRM5 protein, humanNerve Tissue ProteinsPDE4D protein, humanReceptor, Metabotropic Glutamate 5Recombinant Fusion ProteinsRNA, Long NoncodingRNA, Messenger

Identifiers

PMID29880880
PMCPMC6294736
OpenAlexW2806074053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.